和田男人精子质量低检查和田哪个医院看男科好医院,和田那家医院的男科好,和田怀孕22天不想要怎么处理,和田孕前体检那家医院比较好,和田男科看那好,和田重点医院男科到哪好,和田妇女上环哪家医院好

BERLIN, June 5 (Xinhua) -- German authority said on Sunday that bean sprouts might be the "most convincing" source for the E. coli outbreak which has killed 22 people and infected more than 2,000 in the Europe.Gert Lindemann, Agriculture Minister of the state Lower Saxony, told reporters in a press conference that restaurants and food outlets where the cases of E. coli had been reported all had received shipments of the particular bean sprouts.A related company in the Uelzen region has been shut down and its products have been recalled, he said."It is the most convincing... source for the E. coli outbreak," Lindemann said. Although a conclusive laboratory analysis will not come out until Monday, current indications were strong enough to issue a public warning, he said.Authorities have been racing to track down the source of the pathogen since the outbreak, which has infected people in 12 countries - all of whom had once traveled in northern Germany. More than 600 of those infected have developed Hemolytic Uremic Syndrome (HUS), a potentially deadly complication attacking the kidneys.The source of E.coli was first thought to be the cucumbers from Spain, which has caused huge loses for Spain farmers. However, this conclusion was overthrown by Laboratory tests in Hamburg on Tuesday.

BEIJING, Aug. 3 (Xinhuanet) -- The first man in Britain who received a complete plastic heart is allowed to leave hospital and live a relatively normal life at home.Matthew Green, 40, who was dying from arrhythmogenic right ventricular cardiomyopathy, was awaiting a transplant when his condition became so bad that the doctors at Papworth Hospital, the world renowned heart center near Cambridge, decided to give him Britain’s first ever full artificial heart.During a six-hour operation on June 9, 2011, surgeons replaced Mr Green's damaged heart with the device which will serve the role of muscles and ventricles.Unlike previous artificial hearts, they have usually only replaced parts of the organ, the new one is powered by a pump which sits outside the body and can be held in a backpack or shoulder bag.All Mr Green has to do is replace the batteries in the pump every few hours and the heart should last up to three years.Transplant milestones1964 US National Institutes of Health starts artificial heart programme.1966 First transplant of partial mechanical heart, to assist pumping of ventricle.1969 Texas man receives first total artificial heart transplant. After 64 hours on the mechanical device received a donor organ, but died within two days.1982 Artificial heart designed by Utah University doctor Robert Jarvik implanted into man who survived for 112 days.2001 First surgical implant of internally powered artificial heart, which was charged via transduction through skin.

SAN FRANCISCO, Sept. 22 (Xinhua) -- Facebook on Thursday introduced a new feature called Open Graph, enabling users to access and share a wide range of media and lifestyle content on the social network site.According to Facebook's chief executive officer (CEO) Mark Zuckerberg, Open Graph lets users share what they are doing in Facebook-connected apps as they are doing it.These social apps focus on media apps including books, news, music, TV, movies and games, as well as lifestyle apps such as exercise, food, fashion and travel."The last five years of social networking have been about getting people signed up, and getting people connected with their lives. The next five years are going to be defined by the apps and depth of engagement," the young CEO said in a keynote speech at Facebook's f8 developer conference.Take music for example, Facebook integrates with European music streaming service Spotify. If one's Spotify account is connected to Facebook, a message will show up in the Ticker stating the song one is listening to and in the Timeline, a new design of one's profile page. The friends of the user can listen to the same song at the same time by hovering mouse over the song in Timeline or Ticker.Spotify founder and CEO Daniel Ek and movie streaming service Netflix CEO Reed Hastings also took stage as guest speakers to introduce their partnership with Facebook.Zuckerberg also introduced social news reading applications from major news organizations such as The Washington Post and Yahoo News, which allow users to access the content directly on Facebook.Earlier at the f8 conference, Timeline was unveiled as a new feature. It is a new profile design allowing users to scroll vertically through the big moments of one's life in a single page.Zuckerberg assured users that they have complete control over their Timeline, saying they can decide what content will appear and who can see it. The new feature will be available in a few weeks.Since Google launched its own social network "Google+" in June, Facebook has been in a combat mode, striving to roll out new products and features to beat the search giant. In his keynote speech on Thursday, Zuckerberg said half a billion people now use Facebook every day.Two days before the f8 conference, Google announced to open its social network to the public, noting it has introduced 100 new features in the three-month trial.

BEIJING, Aug. 22 (Xinhuanet) -- U.S. presidential candidate Rick Perry's controversial stem-cell treatment may inspire desperate patients to follow his lead while causing medical and legal concerns, according to media reports Monday.The Texas governor underwent a procedure on July 1 where stem cells, made from fat taken from his body, were put into his bloodstream to see if they might find their way to fix a bad back.The treatment carries potential risks ranging from blood clots to infection to cancer and may even run afoul of federal rules, doctors say. File photo of U.S. Republican presidential candidate Texas Governor Rick Perry."As a highly influential person of power, Perry’s actions have the unfortunate potential to push desperate patients into the clinic of quacks,” Harvard’s stem cell expert George Daley told the Associated Press.Worries about the safety and wisdom of this treatment are widespread among stem cell researchers as such a treatment has not been thoroughly vetted by researchers or approved by the FDA.